Targeted therapy in severe asthma today: focus on immunoglobulin E.
about
Dupilumab for the treatment of asthma.Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid.Asthma and poly(ADP-ribose) polymerase inhibition: a new therapeutic approach.Omalizumab for severe asthma: toward personalized treatment based on biomarker profile and clinical history.TH17-Induced Neutrophils Enhance the Pulmonary Allergic Response Following BALB/c Exposure to House Dust Mite Allergen and Fine Particulate Matter From California and ChinaImprovement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study
P2860
Targeted therapy in severe asthma today: focus on immunoglobulin E.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Targeted therapy in severe asthma today: focus on immunoglobulin E.
@en
type
label
Targeted therapy in severe asthma today: focus on immunoglobulin E.
@en
prefLabel
Targeted therapy in severe asthma today: focus on immunoglobulin E.
@en
P2093
P2860
P921
P356
P1476
Targeted therapy in severe asthma today: focus on immunoglobulin E.
@en
P2093
Andrea Matucci
Girolamo Pelaia
Pierluigi Paggiaro
Rossella Paolini
P2860
P304
P356
10.2147/DDDT.S130743
P407
P5008
P577
2017-06-29T00:00:00Z